Login
$MDGL
$440.33 +$2.59 (0.59%) Close

Company Executives

$MDGL Management Team

Mr. Julian Baker

Independent Chairman of the Board

Age 58
Compensation $484.9K USD
Sex Male

Mr. Bill Sibold

President

Chief Executive Officer

Director

Age 58
Compensation $12.21M USD
Sex Male

Ms. Carole Huntsman

Executive Vice President

Chief Commercial Officer

Age 60
Compensation $3.949M USD
Sex Female

Dr. David Soergel

Executive Vice President

Chief Medical Officer

Age 57
Compensation -
Sex Male

Ms. Mardi Dier

Chief Financial Officer

Executive Vice President

Principal Financial Officer

Age 61
Compensation $8.752M USD
Sex Female

Ms. Shannon Kelley

Executive Vice President

Chief Legal Counsel

Age 50
Compensation $4.674M USD
Sex Female

Ms. Rita Thakkar

Senior Vice President

Chief Accounting Officer

Principal Accounting Officer

Age 52
Compensation -
Sex Female
Directors
9
serving now
Independent
6 of 9
stated in the proxy
Average tenure
4.8 years
from year joined
CEO also chairs the board
No
Julian C. Baker
Director Age On board Independent Committees Other public boards 2025 pay Source
Julian C. Baker
59 2023
3 years
Independent None stated Incyte Corporation, Acadia Pharmaceuticals, Inc., Denali Therapeutics Inc. $503,397
Daniel J. Brennan
60 2025
1 year
Independent None stated Waters Corporation $613,097
Raymond Cheong, M.D., Ph.D.
44 2023
3 years
Independent
Compensation Committee Science and Technology Committee · Chair
vTv Therapeutics Inc. $494,897
James M. Daly
64 2019
7 years
Independent
Audit Committee Nominating and Governance Committee
Acadia Pharmaceuticals, Inc., argenx SE, Cytokinetics Inc. $477,022
Jacqualyn A. Fouse, Ph.D.
64 2025
1 year
Independent
Audit Committee Compensation Committee Nominating and Governance Committee
Incyte, Agios $761,744
Richard S. Levy, M.D.
68 2016
10 years
Independent
Compensation Committee · Chair Nominating and Governance Committee Science and Technology Committee
ProTara Therapeutics, Inc., Kodiak Sciences, Inc., Kiniksa Pharmaceuticals, Ltd. $494,897
Bill Sibold
59 2023
3 years
Not independent None stated None stated Paid as CEO
Rebecca Taub, M.D.
74 2016
10 years
Not independent None stated BriaCell Therapeutics Corp., Inc. Not stated
Paul A. Friedman, M.D.
Not stated Not stated Not independent
Science and Technology Committee
None stated $469,147

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support